This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Mar;30(3):340.

doi: 10.1002/mds.26185. Epub 2015 Feb 20.

USP30: a new promising target for Parkinson's disease?

S Thobois¹

Affiliations

Affiliation

¹ Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Neurologie C, Lyon, France; Université de Lyon, Université Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux, Lyon, France; CNRS, Centre des Neurosciences Cognitives, Bron, France.

PMID: 25702807
DOI: 10.1002/mds.26185

Comment

USP30: a new promising target for Parkinson's disease?

S Thobois. Mov Disord. 2015 Mar.

. 2015 Mar;30(3):340.

doi: 10.1002/mds.26185. Epub 2015 Feb 20.

Author

S Thobois¹

Affiliation

¹ Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Neurologie C, Lyon, France; Université de Lyon, Université Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux, Lyon, France; CNRS, Centre des Neurosciences Cognitives, Bron, France.

PMID: 25702807
DOI: 10.1002/mds.26185

No abstract available

PubMed Disclaimer

Comment on

The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy.
Bingol B, Tea JS, Phu L, Reichelt M, Bakalarski CE, Song Q, Foreman O, Kirkpatrick DS, Sheng M. Bingol B, et al. Nature. 2014 Jun 19;510(7505):370-5. doi: 10.1038/nature13418. Epub 2014 Jun 4. Nature. 2014. PMID: 24896179

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley